Cargando…

Reversible exposure of hydrophobic residues on albumin as a novel strategy for formulation of nanodelivery vehicles for taxanes

BACKGROUND: We report herein a novel strategy for the preparation of protein-based nanode-livery vehicles for hydrophobic active pharmaceutical ingredients. METHODS: The procedure consisted of three steps, ie, exposure of hydrophobic residues of a protein to a pH-induced partial unfolding: interacti...

Descripción completa

Detalles Bibliográficos
Autores principales: Garro, AG, Beltramo, DM, Alasino, RV, Leonhard, V, Heredia, V, Bianco, ID
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148845/
https://www.ncbi.nlm.nih.gov/pubmed/21822381
http://dx.doi.org/10.2147/IJN.S19163
_version_ 1782209380167450624
author Garro, AG
Beltramo, DM
Alasino, RV
Leonhard, V
Heredia, V
Bianco, ID
author_facet Garro, AG
Beltramo, DM
Alasino, RV
Leonhard, V
Heredia, V
Bianco, ID
author_sort Garro, AG
collection PubMed
description BACKGROUND: We report herein a novel strategy for the preparation of protein-based nanode-livery vehicles for hydrophobic active pharmaceutical ingredients. METHODS: The procedure consisted of three steps, ie, exposure of hydrophobic residues of a protein to a pH-induced partial unfolding: interaction between hydrophobic residues on the protein and the hydrophobic active pharmaceutical ingredient, and a final step where the structure of the protein was reversed to a native-like state by returning to neutral pH. As proof of concept, the interaction of paclitaxel with partially unfolded states of human serum albumin was evaluated as a potential method for the preparation of water-soluble complexes of the taxane with albumin. RESULTS: We found that paclitaxel readily binds to pH-induced partially unfolded albumin, leading to the formation of optically clear water-soluble complexes. The complexes thus formed were more stable in solution when the albumin native state was at least partially restored by neutralization of the solution to a pH around 7. It was also observed that the hydrodynamic radius of human serum albumin was only slightly increased after the cycle of pH changes, remaining in a monomeric state with a size according to paclitaxel binding. Furthermore, paclitaxel binding did not affect the overall exposure of charged groups of human serum albumin, as evaluated by its interaction with an ionic exchange resin. CONCLUSION: The in vitro biological activity of the complexes formed was qualitatively equivalent to that of a Cremophor(®)-based formulation.
format Online
Article
Text
id pubmed-3148845
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-31488452011-08-05 Reversible exposure of hydrophobic residues on albumin as a novel strategy for formulation of nanodelivery vehicles for taxanes Garro, AG Beltramo, DM Alasino, RV Leonhard, V Heredia, V Bianco, ID Int J Nanomedicine Methodology BACKGROUND: We report herein a novel strategy for the preparation of protein-based nanode-livery vehicles for hydrophobic active pharmaceutical ingredients. METHODS: The procedure consisted of three steps, ie, exposure of hydrophobic residues of a protein to a pH-induced partial unfolding: interaction between hydrophobic residues on the protein and the hydrophobic active pharmaceutical ingredient, and a final step where the structure of the protein was reversed to a native-like state by returning to neutral pH. As proof of concept, the interaction of paclitaxel with partially unfolded states of human serum albumin was evaluated as a potential method for the preparation of water-soluble complexes of the taxane with albumin. RESULTS: We found that paclitaxel readily binds to pH-induced partially unfolded albumin, leading to the formation of optically clear water-soluble complexes. The complexes thus formed were more stable in solution when the albumin native state was at least partially restored by neutralization of the solution to a pH around 7. It was also observed that the hydrodynamic radius of human serum albumin was only slightly increased after the cycle of pH changes, remaining in a monomeric state with a size according to paclitaxel binding. Furthermore, paclitaxel binding did not affect the overall exposure of charged groups of human serum albumin, as evaluated by its interaction with an ionic exchange resin. CONCLUSION: The in vitro biological activity of the complexes formed was qualitatively equivalent to that of a Cremophor(®)-based formulation. Dove Medical Press 2011 2011-06-13 /pmc/articles/PMC3148845/ /pubmed/21822381 http://dx.doi.org/10.2147/IJN.S19163 Text en © 2011 Garro et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Methodology
Garro, AG
Beltramo, DM
Alasino, RV
Leonhard, V
Heredia, V
Bianco, ID
Reversible exposure of hydrophobic residues on albumin as a novel strategy for formulation of nanodelivery vehicles for taxanes
title Reversible exposure of hydrophobic residues on albumin as a novel strategy for formulation of nanodelivery vehicles for taxanes
title_full Reversible exposure of hydrophobic residues on albumin as a novel strategy for formulation of nanodelivery vehicles for taxanes
title_fullStr Reversible exposure of hydrophobic residues on albumin as a novel strategy for formulation of nanodelivery vehicles for taxanes
title_full_unstemmed Reversible exposure of hydrophobic residues on albumin as a novel strategy for formulation of nanodelivery vehicles for taxanes
title_short Reversible exposure of hydrophobic residues on albumin as a novel strategy for formulation of nanodelivery vehicles for taxanes
title_sort reversible exposure of hydrophobic residues on albumin as a novel strategy for formulation of nanodelivery vehicles for taxanes
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148845/
https://www.ncbi.nlm.nih.gov/pubmed/21822381
http://dx.doi.org/10.2147/IJN.S19163
work_keys_str_mv AT garroag reversibleexposureofhydrophobicresiduesonalbuminasanovelstrategyforformulationofnanodeliveryvehiclesfortaxanes
AT beltramodm reversibleexposureofhydrophobicresiduesonalbuminasanovelstrategyforformulationofnanodeliveryvehiclesfortaxanes
AT alasinorv reversibleexposureofhydrophobicresiduesonalbuminasanovelstrategyforformulationofnanodeliveryvehiclesfortaxanes
AT leonhardv reversibleexposureofhydrophobicresiduesonalbuminasanovelstrategyforformulationofnanodeliveryvehiclesfortaxanes
AT herediav reversibleexposureofhydrophobicresiduesonalbuminasanovelstrategyforformulationofnanodeliveryvehiclesfortaxanes
AT biancoid reversibleexposureofhydrophobicresiduesonalbuminasanovelstrategyforformulationofnanodeliveryvehiclesfortaxanes